Click on a filter below to refine your search. Remove a filter to broaden your search.
Compared with those without COVID-19, similar deficits were seen for those in whom symptoms resolved in less than four or at least 12 weeks.
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.